COVID-19 Vaccine Studies On Spike Protein, Coadministration Reflect New US FDA Paradigm

 
• By Sue Sutter and Sarah Karlin-Smith
  
Pole vault
The FDA is setting the bar higher for COVID-19 vaccine immunogenicity studies and coadministration language. (Shutterstock)

More from Vaccines

More from United States